News
Two FDA clearances add diabetes technology options
The FDA has cleared Abbott Freestyle Libre versions 2 and 3 for integration with automated insulin delivery systems and Bigfoot Biomedical’s...
News
Lilly cuts insulin price by 70%, caps out-of-pocket cost
As of May 1, nonbranded insulins will cost $25 a vial, and Lilly says it will immediately cap out-of-pocket costs at $35 per month.
News
Old drug verapamil may have new use in type 1 diabetes
In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.
News
Real-time CGM plus insulin pump best for type 1 diabetes
Real-time continuous glucose monitoring and insulin pump use yielded more time in target glucose range vs. intermittently scanned CGM and...
News
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
News
Type 1 diabetes no longer a disease of the thin: Lifestyle advice needed
The prevalence of overweight/obesity was similar for people with type 1 diabetes and those without diabetes in a nationwide survey.
News
Eye check important before starting semaglutide for diabetes
Meta-analysis finds small increased risk of retinopathy worsening after starting injectable semaglutide.
News
FDA okays Tidepool Loop app to help guide insulin delivery
Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older...
News
FDA approves new type 2 diabetes drug bexagliflozin
Another SGLT2 inhibitor has been approved for type 2 diabetes based on results from 23 clinical trials in 5,000 patients.
News
Metformin monotherapy not always best start in type 2 diabetes
Findings suggest that at time of type 2 diabetes diagnosis some might not benefit from metformin as first-line treatment. Dual or other therapy...
News
Oramed oral insulin fails to meet goal in type 2 diabetes
Top-line results from the phase 3 trial of ORMD-0801 show that the oral insulin product didn’t meet the trial’s endpoint for change from baseline...
News
Latest steps toward reducing U.S. insulin cost begin in 2023
Beneficiaries who take insulin via pen or syringe, covered under Medicare part D, fall under the $35/month co-pay cap.
News
Dubious diagnosis: Is there a better way to define ‘prediabetes’?
There have been major increases in prediabetes in the United States and globally over the past 2 decades.
News
ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids
The new 2023 American Diabetes Association Standards of Care address management of diabetes and its complications, as well as social determinants...
News
FDA okays Dexcom G7 continuous glucose monitoring system
The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.